CalciMedica Net Interest Income from 2010 to 2026
| CALC Stock | 0.90 0.12 11.76% |
Net Interest Income | First Reported 2010-12-31 | Previous Quarter -99 K | Current Value -94 K | Quarterly Volatility 228.5 K |
Check CalciMedica Common financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CalciMedica Common's main balance sheet or income statement drivers, such as Depreciation And Amortization of 49.6 K, Selling General Administrative of 12 M or Other Operating Expenses of 23.8 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.61. CalciMedica financial statements analysis is a perfect complement when working with CalciMedica Common Valuation or Volatility modules.
CalciMedica | Net Interest Income | Build AI portfolio with CalciMedica Stock |
Analyzing CalciMedica Common's Net Interest Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Interest Income has evolved provides context for assessing CalciMedica Common's current valuation and future prospects.
Latest CalciMedica Common's Net Interest Income Growth Pattern
Below is the plot of the Net Interest Income of CalciMedica Common Stock over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. CalciMedica Common's Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CalciMedica Common's overall financial position and show how it may be relating to other accounts over time.
| Net Interest Income | 10 Years Trend |
|
Net Interest Income |
| Timeline |
CalciMedica Net Interest Income Regression Statistics
| Arithmetic Mean | 256,526 | |
| Geometric Mean | 258,474 | |
| Coefficient Of Variation | 89.08 | |
| Mean Deviation | 198,025 | |
| Median | 393,000 | |
| Standard Deviation | 228,526 | |
| Sample Variance | 52.2B | |
| Range | 685K | |
| R-Value | (0.73) | |
| Mean Square Error | 26.2B | |
| R-Squared | 0.53 | |
| Significance | 0.0009 | |
| Slope | (32,957) | |
| Total Sum of Squares | 835.6B |
CalciMedica Net Interest Income History
About CalciMedica Common Financial Statements
CalciMedica Common stakeholders use historical fundamental indicators, such as CalciMedica Common's Net Interest Income, to determine how well the company is positioned to perform in the future. Although CalciMedica Common investors may analyze each financial statement separately, they are all interrelated. For example, changes in CalciMedica Common's assets and liabilities are reflected in the revenues and expenses on CalciMedica Common's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CalciMedica Common Stock. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | -99 K | -94 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether CalciMedica Common Stock offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CalciMedica Common's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Calcimedica Common Stock Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Calcimedica Common Stock Stock:Check out the analysis of CalciMedica Common Correlation against competitors. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Will Biotechnology sector continue expanding? Could CalciMedica diversify its offerings? Factors like these will boost the valuation of CalciMedica Common. Projected growth potential of CalciMedica fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every CalciMedica Common data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of CalciMedica Common Stock is measured differently than its book value, which is the value of CalciMedica that is recorded on the company's balance sheet. Investors also form their own opinion of CalciMedica Common's value that differs from its market value or its book value, called intrinsic value, which is CalciMedica Common's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because CalciMedica Common's market value can be influenced by many factors that don't directly affect CalciMedica Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between CalciMedica Common's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CalciMedica Common should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, CalciMedica Common's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.